FRANK KARBE - 10 Dec 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Chief Financial Officer
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
10 Dec 2025
Transactions value $
-$1,600,884
Form type
4
Filing time
12 Dec 2025, 19:41:47 UTC
Previous filing
05 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KARBE FRANK Chief Financial Officer 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO /s/ Shane Ward, Attorney-in-Fact 12 Dec 2025 0001276700

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Tax liability -$1.6M -7.29K -12.6% $219.60 50.6K 10 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for taxes on RSU vesting.
F2 Includes 352 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2025.